Genturi Inc. is a newly formed genomics startup. The company’s mission is to fully develop integrated platforms for the rapid delivery of low-cost, high-resolution genomic maps for clinical and non-clinical research and diagnostics.
Genturi’s platforms will revolutionize the study of all forms of structural variants, providing low-cost and high-speed access to this presently difficult to acquire genomic information. The ease of accessibility to structural will accelerate the corresponding associations with disease states and clinical adoption. With powerful purpose-built platforms, Genturi promises to provide compelling sample-to-answer solutions to researchers and clinicians alike.